Stockholders' Equity (Details) - USD ($)
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
Feb. 02, 2024 |
Jan. 15, 2024 |
Dec. 06, 2023 |
Sep. 15, 2022 |
Jan. 04, 2022 |
Mar. 31, 2018 |
Feb. 29, 2024 |
Feb. 28, 2023 |
Feb. 29, 2024 |
Feb. 28, 2023 |
May 31, 2022 |
Nov. 28, 2023 |
Nov. 27, 2023 |
May 31, 2023 |
Sep. 14, 2022 |
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares Authorized |
|
|
|
|
|
|
345,000,000
|
|
345,000,000
|
|
|
350,000,000
|
187,500,000
|
187,500,000
|
|
| Common Stock, Par or Stated Value Per Share (in Dollars per share) |
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
$ 0.0001
|
|
| Preferred Stock, Shares Authorized |
|
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
|
|
|
5,000,000
|
|
| Preferred Stock, Par or Stated Value Per Share (in Dollars per share) |
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
|
$ 0.001
|
|
| Stockholders' Equity, Reverse Stock Split |
|
|
|
1-for-4
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Outstanding |
|
|
|
72,517,570
|
|
|
137,675,276
|
|
137,675,276
|
|
|
|
|
72,543,141
|
290,070,272
|
| Stock Issued During Period, Shares, Reverse Stock Splits |
|
|
|
217,552,702
|
|
|
|
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, Stock Splits |
|
|
|
576
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) |
|
|
$ 0.0345
|
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
|
|
|
|
|
$ 0
|
$ 11,532,680
|
|
|
|
|
|
| Litigation Settlement, Expense (in Dollars) |
|
|
|
|
|
|
|
|
|
$ 1,250,000
|
|
|
|
|
|
| Share Return |
|
|
|
|
|
|
|
|
|
13,174,402
|
|
|
|
|
|
| Number of Warrants Cancelled |
|
|
|
|
|
|
|
|
|
454,548
|
|
|
|
|
|
| Class of Warrant or Rights, Granted |
|
|
|
|
757,576
|
51,310
|
|
|
0
|
|
20,232,775
|
|
|
|
|
| Gain (Loss) on Extinguishment of Debt (in Dollars) |
|
|
|
|
|
|
$ (3,404,910)
|
$ 0
|
$ (3,404,910)
|
$ (6,659,359)
|
|
|
|
|
|
| Debt Instrument, Issued, Principal (in Dollars) |
|
|
|
|
$ 2,500,000
|
|
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Term |
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Face Amount (in Dollars) |
|
|
|
$ 18,846,721
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Convertible, Conversion Price (in Dollars per share) |
|
|
|
$ 0.4
|
|
|
|
|
|
|
|
|
|
|
$ 1.2
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|
|
|
6,801,298
|
|
|
|
|
|
|
|
|
|
|
3,400,652
|
| Warrant Description |
|
|
|
each warrants issuable pursuant to the conversion of such debentures is exercisable for one share of the Company’s common stock at a price of $0.40 per share
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
|
|
|
|
|
|
|
|
8,250,000
|
|
|
|
|
|
|
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 0.039
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Expense (in Dollars) |
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars) |
|
|
|
|
|
|
$ 3,678
|
$ 0
|
$ 3,678
|
$ 0
|
|
|
|
|
|
| Share Price (in Dollars per share) |
|
|
|
|
|
|
$ 0.0495
|
|
$ 0.0495
|
|
|
|
|
|
|
| To Be Issued to Officers [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) |
|
|
|
|
|
$ 5
|
|
|
|
|
|
|
|
|
|
| WestPark Capital Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unit, Description |
|
|
|
|
|
Each unit consists of four shares of common stock and one warrant to purchase a share of common stock for $3.00.
|
|
|
|
|
|
|
|
|
|
| Four Convertible Notes Payable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued |
|
32,132,135
|
32,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) |
|
$ 0.0333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Four Convertible Notes Payable [Member] | Principal [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
$ 1,070,000
|
$ 960,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Four Convertible Notes Payable [Member] | Accrued Interest [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
$ 144,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Canaccord Debentures [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued |
|
|
|
28,414,149
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) |
|
|
|
$ 0.4
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
$ 8,098,033
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Rights, Granted |
|
|
|
14,207,075
|
|
|
|
|
|
|
|
|
|
|
|
| Gain (Loss) on Extinguishment of Debt (in Dollars) |
|
|
|
$ 4,547,660
|
|
|
|
|
|
|
|
|
|
|
|
| Canaccord Debentures [Member] | Principal [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
7,965,278
|
|
|
|
|
|
|
|
|
|
|
|
| Canaccord Debentures [Member] | Accrued Interest [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
$ 132,755
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. Convertible Debentures [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued |
|
|
|
12,051,397
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) |
|
|
|
$ 0.4
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
$ 3,434,647
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Rights, Granted |
|
|
|
6,025,700
|
|
|
|
|
|
|
|
|
|
|
|
| Gain (Loss) on Extinguishment of Debt (in Dollars) |
|
|
|
$ 2,111,699
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. Convertible Debentures [Member] | Principal [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
3,378,342
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. Convertible Debentures [Member] | Accrued Interest [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount (in Dollars) |
|
|
|
$ 56,305
|
|
|
|
|
|
|
|
|
|
|
|
| Board of Directors Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture |
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares Issued, Price Per Share (in Dollars per share) |
|
$ 0.0388
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Expense (in Dollars) |
|
|
|
|
|
|
|
|
$ 6,439
|
|
|
|
|
|
|
| Chief Executive Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
6,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) |
$ 0.039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period |
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vice President [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) |
$ 0.039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period |
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chief Accounting Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) |
$ 0.039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period |
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chief Operating Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) |
$ 0.039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period |
24 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chief Scientific Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) |
$ 0.039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term |
10 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period |
24 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|